Levetiracetam Actavis Group

Levetiracetam, the active ingredient in Levetiracetam Actavis Group, is an antiepileptic presented as a tablet for oral use. It is prescribed to control various types of epileptic seizures in adults and children.

GNH USA supplies Levetiracetam Actavis Group as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic agent that reduces abnormal neuronal firing in the brain. - Partial seizures: helps achieve seizure freedom or significant reduction in frequency. - Generalized tonic‑clonic seizures: contributes to control of convulsive episodes. - Myoclonic seizures: reduces the occurrence of sudden muscle jerks.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Dizziness: transient feeling of light‑headedness. - Fatigue: increased tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: occasional stomach upset. - Nasal congestion: mild blockage of nasal passages.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or breathing difficulty. - Mood disorders: depression or suicidal thoughts. - Hematologic changes: low blood cell counts. - Hepatic dysfunction: elevated liver enzymes. - Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Multiorgan hypersensitivity: systemic inflammatory response.

Before initiating therapy, clinicians should evaluate patient history and monitor for specific risks. - Renal function: adjust dose in patients with impaired clearance. - Pregnancy: category B, discuss potential benefits versus risks. - Concomitant CNS depressants: monitor for additive sedation. - Psychiatric history: observe for mood changes or suicidal ideation. - Elderly patients: start at lower dose and titrate cautiously. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Levetiracetam can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam exposure. - Phenytoin: may decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: increased central nervous system depression. - Other antiepileptics (e.g., valproate): monitor for additive side effects. - Hormonal contraceptives: possible reduction in contraceptive effectiveness.